Type 2

Review of new once-weekly Type 2 diabetes drugs

Once-weekly glucagon-like peptide-1 receptor agonists (GLP-1RAs) differ in their efficacy and safety profiles, according to new research by the University of Leicester. Compared to other…
Pages